PPARGC1A and acute kidney injury: That is, the systemic administration of crotonate prevents the decrease of PGC1α and sirtuin-3 expression, and the increase of CCL2 expression in mice with AKI and this was associated to protection from experimental nephrotoxic AKI and preservation of renal function (Justo et al., 2006).